Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
IMPORTANCE: As of March 2015, 23 states and the District of Columbia had medical marijuana laws in place. Physicians should know both the scientific rationale and the practical implications for medical marijuana laws. OBJECTIVE: To review the pharmacology, indications, and laws related to medical marijuana use. EVIDENCE REVIEW: The medical literature on medical marijuana was reviewed from 1948 to March 2015 via MEDLINE with an emphasis on 28 randomized clinical trials of cannabinoids as pharmacotherapy for indications other than those for which there are 2 US Food and Drug Administration-approved cannabinoids (dronabinol and nabilone), which include nausea and vomiting associated with chemotherapy and appetite stimulation in wasting illnesses. FINDINGS: Use of marijuana for chronic pain, neuropathic pain, and spasticity due to multiple sclerosis is supported by high-quality evidence. Six trials that included 325 patients examined chronic pain, 6 trials that included 396 patients investigated neuropathic pain, and 12 trials that included 1600 patients focused on multiple sclerosis. Several of these trials had positive results, suggesting that marijuana or cannabinoids may be efficacious for these indications. CONCLUSIONS AND RELEVANCE: Medical marijuana is used to treat a host of indications, a few of which have evidence to support treatment with marijuana and many that do not. Physicians should educate patients about medical marijuana to ensure that it is used appropriately and that patients will benefit from its use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e560352009-001 · Cited by 6,921
Adverse health effects of marijuana use.
Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1402309 · Cited by 2,774
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Persistent cannabis users show neuropsychological decline from childhood to midlife
Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S. E., McDonald, K., Ward, A., Poulton, R., & Moffitt, T. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206820109 · Cited by 1,523
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Adverse health effects of non-medical cannabis use
Hall, W., & Degenhardt, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61037-0 · Cited by 1,134
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059
Cannabis use and mental health in young people: cohort study.
Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W. (2002) · BMJ · doi:10.1136/bmj.325.7374.1195 · Cited by 997
Pharmacology and effects of cannabis: A brief review
Ashton, C. H. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.101 · Cited by 934
Cited by
Ligresti, A., De Petrocellis, L., & Di Marzo, V. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 469
Yang, S., & Chang, M. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133130 · Cited by 408
Evidence-Based Nonpharmacologic Strategies for Comprehensive Pain Care
Tick, H., Nielsen, A., Pelletier, K. R., Bonakdar, R., Simmons, S., Glick, R., Ratner, E., Lemmon, R. L., Wayne, P., & Zador, V. (2018) · EXPLORE · doi:10.1016/j.explore.2018.02.001 · Cited by 380
Smart, R., Caulkins, J. P., Kilmer, B., Davenport, S., & Midgette, G. (2017) · Addiction · doi:10.1111/add.13886 · Cited by 369
Challenges towards revitalizing hemp: A multifaceted crop
Schluttenhofer, C., & Yuan, L. (2017) · Trends in Plant Science · doi:10.1016/j.tplants.2017.08.004 · Cited by 348
Blanco, C., Hasin, D. S., Wall, M. M., Flórez-Salamanca, L., Hoertel, N., Wang, S., Kerridge, B. T., & Olfson, M. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3229 · Cited by 336
Medical Marijuana and Marijuana Legalization
Pacula, R. L., & Smart, R. (2017) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032816-045128 · Cited by 284
Cannabis and Pain: A Clinical Review
Hill, K. P., Palastro, M. D., Johnson, B., & Ditre, J. W. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0017 · Cited by 281
Self-citationBradford, A. C., Bradford, W. D., Abraham, A., & Bagwell Adams, G. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.0266 · Cited by 269
Burke, N. N., Finn, D. P., McGuire, B. E., & Roche, M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23802 · Cited by 268
Pergam, S. A., Woodfield, M. C., Lee, C. M., Cheng, G., Baker, K. K., Marquis, S. R., & Fann, J. R. (2017) · Cancer · doi:10.1002/cncr.30879 · Cited by 267
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
Andreae, M. H., Carter, G. M., Shaparin, N., Suslov, K., Ellis, R. J., Ware, M. A., Abrams, D. I., Prasad, H., Wilsey, B., Indyk, D., et al. (2015) · The Journal of Pain · doi:10.1016/j.jpain.2015.07.009 · Cited by 266
Cannabis and mental illness: a review
Lowe, D. J. E., Sasiadek, J. D., Coles, A. S., & George, T. P. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0970-7 · Cited by 253
Cannabis as a substitute for prescription drugs – a cross-sectional study
Corroon, J., Mischley, L., & Sexton, M. (2017) · Journal of Pain Research · doi:10.2147/jpr.s134330 · Cited by 208
Evaluation of hemp (Cannabis sativa L.) as an industrial crop: a review
Rehman, M., Fahad, S., Du, G., Cheng, X., Yang, Y., Tang, K., Liu, L., Liu, F.-H., & Deng, G. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16264-5 · Cited by 199
Häuser, W., Petzke, F., & Fitzcharles, M. A. (2018) · European Journal of Pain · doi:10.1002/ejp.1118 · Cited by 175
Bradford, A. C., & Bradford, W. D. (2017) · Health Affairs · doi:10.1377/hlthaff.2016.1135 · Cited by 172
Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity
Weizman, L., Dayan, L., Brill, S., Nahman-Averbuch, H., Hendler, T., Jacob, G., & Sharon, H. (2018) · Neurology · doi:10.1212/wnl.0000000000006293 · Cited by 120
Wen, H., Hockenberry, J. M., & Druss, B. G. (2019) · Prevention Science · doi:10.1007/s11121-018-0903-8 · Cited by 107
“…debilitating medical conditions (e.g., HIV-AIDS, cachexia, cancer, glaucoma, epilepsy and other seizure disorders, muscle spasms frommultiple sclerosis, or Crohn’s disease), for which the potential benefits of marijuana would likely outweigh the health risks (Hill 2015; Hoffmann and Weber 2010).”
Botsford, S. L., Yang, S., & George, T. P. (2020) · The American Journal on Addictions · doi:10.1111/ajad.12963 · Cited by 88
Tafelski, S., Häuser, W., & Schäfer, M. (2016) · Der Schmerz · doi:10.1007/s00482-015-0092-3 · Cited by 71
Bellnier, T., Brown, G. W., & Ortega, T. R. (2018) · Mental Health Clinician · doi:10.9740/mhc.2018.05.110 · Cited by 48
“Evidence supporting medical cannabis (MC) as an effective treatment for chronic and refractory pain is expanding and drawing the attention of both advocates and critics alike.(12-18) Two compounds present in cannabis, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), are responsible for a majority of the drug’…”
BackgroundMelander, L. A., & Marganski, A. J. (2020) · Cyberpsychology: Journal of Psychosocial Research on Cyberspace · doi:10.5817/cp2020-1-1 · Cited by 39
Cannabis in liver disorders: a friend or a foe?
Goyal, H., Rahman, M. R., Perisetti, A., Shah, N., & Chhabra, R. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001256 · Cited by 33
Demes, J. S., McNair, B., & Taylor, M. R. G. (2020) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61837 · Cited by 30
Metadata
- Authors
- Hill, K. P.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-06-23
- Volume
- 313
- Issue
- 24
- Pages
- 2474
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2112074033
- Cited by
- 508
- References
- 63
- FWCI
- 36.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.